Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
Apply
CBP-1019, FOLFOX, Bevacizumab, Pembrolizumab, Enzalutamide
Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step